hsa-miR-335

ncRNA information

ncRNA name

hsa-miR-335

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

SETD8

Cancer information

Cancer name

Breast Cancer

Cancer site

Breast

Treatment information

Treatment type

Chemotherapy

Drug

Paclitaxel

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

VMIP-II reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer.

Tissue resource

human breast cancer cell lines SKBR-3

human breast cancer cell lines MCF-7

human breast cancer paclitaxel-resistant cell lines SKBR-3/PR

human breast cancer paclitaxel-resistant cell lines MCF-7/PR

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Country

Continent